Selective adenosine A(2A) receptor inhibitor SCH58261 reduces oligodendrocyte loss upon brain injury in young rats

Cellular elements of maturing brain are vulnerable to insults, which lead to neurodevelopmental defects. There are no established treatments at present. Here we examined the efficacy of selective adenosine A(2A) receptor inhibitor SCH58261 to combat brain injury, particularly oligodendrocyte (OL) li...

Descripción completa

Detalles Bibliográficos
Autores principales: Al-Griw, Mohamed A., Alghazeer, Rabia O., Awayn, Nuri, Shamlan, Ghalia, Eskandrani, Areej A., Alnajeebi, Afnan M., Babteen, Nouf A., Alansari, Wafa S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7783643/
https://www.ncbi.nlm.nih.gov/pubmed/33424311
http://dx.doi.org/10.1016/j.sjbs.2020.09.063

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7783643/
https://www.ncbi.nlm.nih.gov/pubmed/33424311
http://dx.doi.org/10.1016/j.sjbs.2020.09.063

Ejemplares similares